AMENDMENT TO INCLUDE RESEARCH ON THE CO-OCCURRENCE AND HEALTHCONSEQUENCES OF VIOLENCE, DRUG ABUSE, AND HIV/AIDS

 

NIH GUIDE, Volume 25, Number 6, March 1, 1996

 

PA NUMBER:  PA-95-072, International Epidemiology Research on Drug

Abuse

PA-95-060, Drug and Alcohol Use and Abuse in Rural America

PA-95-059, Local Population/Area Epidemiologic Drug Research

PA-95-057, HIV Risk Behaviors, Determinants and Consequences

PA-94-054, Strategies to Reduce HIV Sexual Risk Practices

PA-94-010, Needle Hygiene & Needle Exchange Program Research

PA-94-007, Survey Research on Drug Use/Associated Behaviors

PA-93-111, Partner Notification to HIV-Infected Drug Users

PA-93-046, Drug Abuse in Minority & Underserved Populations

 

P.T. 34



Keywords:

  AIDS 

  Drugs/Drug Abuse 

  Violent Behavior 

  Behavioral/Social Studies/Service 

 

National Institute on Drug Abuse

 

PURPOSE

 

For those investigators applying for new grants or competing

supplements under the program of research sponsored by the National

Institute on Drug Abuse (NIDA) Community Research Branch, this notice

is meant to amend Program Announcements  PA-95-072 (NIH Guide, Vol.

24, No. 2, June 16, 1995), PA-95-060 (NIH Guide, Vol. 24, No. 16, May

12, 1995), PA-95-059 (NIH Guide, Vol. 24, No. 15, May 5, 1995),

PA-95-057 (NIH Guide, Vol. 24, No. 16, May 5, 1995), PA-94-054 (NIH

Guide, Vol. 23, No. 14, April 8, 1994), PA-94-010 (NIH Guide, Vol.

22, No. 40, November 5, 1993),  PA-94-007 (NIH Guide, Vol. 22, No.

39, October 29, 1993), PA-93-111 (NIH Guide, Vol. 22, No. 33,

September 17, 1993), and PA-93-046 (NIH Guide, Vol. 22, No. 5,

February 5, 1993), which are still in effect and should be consulted

in conjunction with this amendment.  (Research on violence has

already been requested under PA-95-083, "Women's HIV Risk and

Protective Behaviors.")  The referenced PAs address rural-, local

area-, and international epidemiologies of drug abuse, including

enhanced survey research on drug use issues; the patterns, causes and

consequences of drug use among minority or underserved populations;

the epidemiologies of drug abuse and HIV/AIDS; and interventions to

reduce behaviors linked to the transmission of HIV among drug users

and their sex partners.

 

This addendum focuses on the co-occurrence, interrelatedness, and

health consequences of three major public health problems: drug

abuse, violence, and HIV/AIDS.  To this end, NIDA will support the

following kinds of studies: (1) local-level community epidemiology

studies to document and monitor trends in the nature, extent, and

patterns of co-occurring drug use, violence, and HIV/AIDS, as well as

their negative health consequences; (2) studies of the common and

unique risk/protective antecedents and correlates of these phenomena;

(3) studies of reciprocal linkages among drug use, violence, and HIV

risk taking (e.g., the effect of drug use on sexual assault or other

HIV risks; the effect of sexual assault or coercion on HIV infection;

the effect of sexual risk-taking on drug use); (4) studies that

design, implement and evaluate interventions to reduce/prevent

drug-related violence and HIV risk behaviors and their negative

health consequences; and (5) methodological studies to improve the

measurement, data collection, and analysis of drug-related violence

and HIV behaviors, or to extend prevailing research paradigms

thereon. In contrast, this addendum will not support research

focusing exclusively on the criminal behavior/criminal justice

outcomes of drug abuse.

 

Populations of concern include high-risk male and female drug

injectors and non-injectors from urban and rural communities as well

as subgroups of the population that are disproportionately at risk

for drug abuse, violence, and HIV/AIDS.  Applications must be

submitted on the grant application form PHS 398 (rev. 5/95) using the

receipt dates outlined in the PHS 398 kit.

 

INQUIRIES

 

Direct inquiries regarding programmatic issues to:

 

Richard Needle, Ph.D., M.P.H. or Susan Coyle, Ph.D.

Division of Epidemiology and Prevention Research

National Institute on Drug Abuse

5600 Fishers Lane, Room 9A-42

Rockville, MD  20857

Telephone:  (301) 443-6720

FAX:  (301) 443-2636

Email:  RNEEDLE@AOADA.SSW.DHHS.GOV or SCOYLE@AOADA.SSW.DHHS.GOV

 

.

Return to 1996 Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.